Atlas Trials

Observational Study of Ibrutinib Use in CLL

Clinical trial NCT03633045 · UNKNOWN

Trial details

NCT number
NCT03633045
Sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Lymphocytic Leukemia
Start date
2018-09-01
Primary completion
2021-09-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.